by Dr. Yashashwini Reddy | Sep 24, 2025
Case Study: Zolgensma (Novartis) – The World’s Most Expensive Drug Background Drug: Zolgensma (onasemnogene abeparvovec) Company: Novartis Gene Therapies (AveXis subsidiary) Indication: Spinal Muscular Atrophy (SMA) – a rare, often fatal genetic disorder in infants....
by Dr. Yashashwini Reddy | Sep 24, 2025
Case Study: Gilead’s Remdesivir during COVID-19 Pandemic Background Remdesivir is an antiviral originally developed by Gilead Sciences for Ebola virus infection. During the COVID-19 pandemic (2020), early in-vitro and clinical data suggested that Remdesivir could...
